ON-DEMAND WEBINARS

Learn how RTSM can be tailored to meet precision medicine’s unique challenges of expiry, visit & personalized shipment management.

 

The DECODE Obesity initiative aims to advance obesity drug development by generating evidence and optimizing digital health technologies to assess treatment benefits beyond weight loss.

Leaders from AstraZeneca, Syneos Health, Sarah Cannon Research Institute, and Medable get candid about where agentic AI is actually earning its keep.

In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor